Skip to main content
    S

    SeaStar Medical Holding Corporation (ICU)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.85
    +0.02 (+1.80%)

    Market Cap: $4.46M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    SeaStar Medical Holding Corporation (ICU) Financials: Revenue, Profit and Cash Flow

    Updated Nov 11, 2026. Financial statements from company filings, amounts in US dollars.

    SeaStar Medical Holding reported revenue of $1.23M for the fiscal year ended Dec 31, 2025, up 814.1% from the year before. That year, net income was -$12.15M with a net margin of -984.6%, operating cash flow was -$13.60M and free cash flow was -$13.60M. The quarter ended Sep 30, 2026 had revenue of $635.00K and net income of -$4.53M.

    Revenue and Margins

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$1.23M+814.1%95.7%-986.6%-984.6%
    Dec 2024$135.00KN/A100.0%-13216.3%-18392.6%
    Dec 2023$0N/AN/AN/AN/A
    Dec 2022$0N/AN/AN/AN/A
    Dec 2021$0N/AN/AN/AN/A
    Dec 2020$0N/AN/AN/AN/A
    Annual, fiscal years ended Dec 2020 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Revenue$1.23M$135.00K$0$0$0$0
    Cost of revenue$53.00K$0$0$0$0N/A
    Gross profit$1.18M$135.00K$0$0$0N/A
    Research and development$7.52M$9.11M$5.97M$2.50M$2.77M$4.03M
    Operating income-$12.18M-$17.84M-$14.21M-$11.61M-$4.45M-$6.45M
    Net income-$12.15M-$24.83M-$26.23M-$12.19M-$4.60M-$3.28M
    EBITDAN/AN/AN/A-$10.11M-$4.25M-$5.24K
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$635.00K$615.00K$495.00K$420.00K$183.00K$338.00K$293.00K$67.00K$68.00K$0$0$0
    Gross profit$587.00K$561.00K$449.00K$408.00K$169.00K$311.00K$293.00K$67.00K$68.00K$0$0N/A
    Operating income-$4.58M-$3.79M-$3.60M-$3.02M-$3.58M-$1.76M-$3.82M-$4.77M-$4.46M-$4.67M-$3.95M-$2.94M
    Net income-$4.53M-$3.73M-$3.52M-$2.90M-$3.47M-$2.00M-$3.77M-$4.42M-$4.48M-$3.24M-$12.70M-$9.46M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $525.00K by $11.46M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Total assets$14.16M$4.66M$3.51M$3.04M$603.00K$269.21K
    Current assets$13.58M$3.77M$2.31M$1.52M$601.00K$38.39K
    Cash and equivalents$11.98M$1.82M$176.00K$47.00K$510.00K$38.39K
    Total liabilities$3.74M$6.84M$17.38M$23.80M$3.42M$249.44K
    Short-term debt$525.00K$574.00K$4.74M$1.18M$2.38M$126.41K
    Long-term debtN/AN/A$4.34M$7.65M$181.00K$63.00K
    Shareholder equity$10.42M-$2.18M-$13.87M-$20.76M-$2.82M$19.76K
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$5.31M$8.65M$11.26M$14.16M$15.53M$8.38M$7.60M$4.66M$4.59M$3.47M$7.74M$3.51M
    Total liabilities$4.84M$4.35M$3.95M$3.74M$4.07M$5.04M$7.03M$6.84M$6.64M$10.37M$12.21M$17.38M
    Cash and equivalents$3.99M$6.96M$9.35M$11.98M$13.76M$6.30M$5.30M$1.82M$2.08M$1.18M$5.02M$176.00K
    Shareholder equity$469.00K$4.30M$7.32M$10.42M$11.46M$3.34M$565.00K-$2.18M-$2.05M-$6.90M-$4.47M-$13.87M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
    Operating cash flow-$13.60M-$16.01M-$10.29M-$7.79M-$5.11M-$5.57M
    Capital expenditures$0$0$0$0$0$5
    Free cash flow-$13.60M-$16.01M-$10.29M-$7.79M-$5.11M-$5.57M
    Financing cash flow$23.76M$17.65M$10.41M$7.33M$2.82M$4.89M
    Fiscal years ended Dec 2020 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$3.37M-$2.99M-$2.76M-$4.09M-$3.84M-$3.01M-$2.65M-$4.69M-$5.00M-$2.82M-$3.49M-$4.49M
    Free cash flowN/AN/A-$2.76M-$4.09M-$3.84M-$3.01M-$2.65M-$4.69M-$5.00M-$2.82M-$3.49M-$4.49M
    Last 12 quarters

    Frequently Asked Questions About ICU

    What is SeaStar Medical Holding's annual revenue?

    SeaStar Medical Holding reported revenue of $1.23M for the fiscal year ended Dec 31, 2025.

    How fast is SeaStar Medical Holding's revenue growing?

    Revenue was up 814.1% for the fiscal year ended Dec 31, 2025 compared with the year before.

    Is SeaStar Medical Holding profitable?

    No. SeaStar Medical Holding reported net income of -$12.15M for the fiscal year ended Dec 31, 2025, with a net margin of -984.6%.

    How much free cash flow does ICU generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$13.60M minus capital expenditures of $0 produced free cash flow of -$13.60M.

    How much debt does SeaStar Medical Holding have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $525.00K and cash and equivalents of $11.98M.